Delivery Order SPE2DB22D1002-SPE2DB25FLJB0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Itraconazole 100 mg capsules in quantities of 30 units at a firm fixed price of $1,081.51. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $2,921.66 to AmerisourceBergen Drug Corp for Itraconazole 100 mg capsules (30-count) on June 3, 2025, with an ultimate completion date of June 4, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,358.00 to AmerisourceBergen Drug Corp for the supply of Itraconazole 100 mg capsules (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Itraconazole 10 mg/ml solution in a 150 ml quantity, with a ceiling value of $10,858.92. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sandimmune 25 mg capsules in unit dose packaging (30 count) with a ceiling value of $2,973.24. This is a firm fixed price delivery order with no set-aside designation, executed under a competitively awarded contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of ITRACONAZOLE 10 MG/ML SOLUTION 150ML, a pharmaceutical product. The award has a total ceiling value of $11,761.16 and an ultimate completion date of September 17, 2024. This contract is not associated with a set-aside program. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen holds several...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,224.08 firm fixed-price delivery order for IMJUDO 25 mg/1.25 mL vials on May 2, 2025, with completion targeted for May 23, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,374.26 delivery order on August 28, 2025, for the supply of SPS 15 GM/60 ML suspension in 473 ML quantities. This is a firm fixed-price, non-set-aside contract with a completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and is issued under the company's...
- The Defense Logistics Agency awarded a $9,532.30 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, a critical antifungal medication used in military and federal healthcare systems. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLJB0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sporanox 100 mg capsules (30-count units) valued at $1,150.34 under a firm fixed-price contract type. The order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the performance from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/23/25 |